Quantifying the relationship of HIV infection with clinicopathological spectrum and outcome among patients with colorectal cancer in a South African population
- PMID: 36407346
- PMCID: PMC9652669
- DOI: 10.4314/ahs.v22i2.4
Quantifying the relationship of HIV infection with clinicopathological spectrum and outcome among patients with colorectal cancer in a South African population
Abstract
Introduction: Literature is limited on HIV and colorectal cancer (CRC) in sub-Saharan Africa despite it being the epicentre of the HIV epidemic.
Purpose: To compare clinicopathological features and outcome of CRC in HIV-negative and HIV-positive patients.
Methods: Retrospective analysis of a prospective CRC database. Demographic details, HIV status, anatomical site, disease stage, treatment and follow-up were documented.
Results: Of 715 patients with CRC, 145 and 570 tested positive and negative respectively for HIV. Median age was 45 (IQR 36-53 and 57 (IQR 45-66) years among HIV-positive and HIV-negative patients respectively (p<0.0001). Tumour differentiation differed between the two groups (p=0.003) but staging was not different (p=0.6). Surgical resection rate was 52% for HIV-positive patients versus 59% for HIV-negative patients (p=0.07). Median follow-up was 9 (IQR 2-20.5) months for HIV-positive patients and 12 (IQR 6-29) months for HIV-negative patients (p=0.154). Recurrence rate was 14.7% among HIV positive patients and 6.8% in HIV negative patients (p=0.089).
Conclusion: When compared with HIV-negative patients, HIV-positive patients with CRC presented at a younger age and tended to have lower surgical resection rates. There was no difference between the two groups with CRC in terms of anatomical sub-site distribution, disease staging and recurrence rates.
Keywords: Colorectal cancer; HIV; Outcome; colon cancer; rectal cancer.
© 2022 Pillay SK et al.
Figures
References
-
- Suneja G, Shiels MS, Angulo R, et al. Cancer treatment disparities in HIV-infected individuals in the United States. J ClinOncol. 2014;32:2344–2350. https://dx.doi.org/10.1200%2FJCO.2013.54.8644 . - PMC - PubMed
-
- Alfa-Wali M, Tait D, Allen-Mersh T, et al. Colorectal cancer in HIV positive individuals: the immunological effects of treatment. Eur J Cancer. 2011;47:2403–2407. - PubMed
-
- Berretta M, Di Benedetto F, Bearz A, et al. FOLFOX-4 regimen with concomitant highly active antiretroviral therapy in metastatic colorectal cancer HIV-infected patients: a report of five cases and review of the literature. Cancer Invest. 2008;26:610–614. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical